866-997-4948(US-Canada Toll Free)

Stelis Biopharma Pvt Ltd - Product Pipeline Review - 2016

Published By :

Global Markets Direct

Published Date : Dec 2016

Category :

Pharmaceutical

No. of Pages : 25 Pages

Stelis Biopharma Pvt Ltd - Product Pipeline Review - 2016

Summary

Global Markets Directs, Stelis Biopharma Pvt Ltd - Product Pipeline Review - 2016, provides an overview of the Stelis Biopharma Pvt Ltds pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Stelis Biopharma Pvt Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Stelis Biopharma Pvt Ltd
- The report provides overview of Stelis Biopharma Pvt Ltd including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Stelis Biopharma Pvt Ltds pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Stelis Biopharma Pvt Ltds out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Stelis Biopharma Pvt Ltds strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Stelis Biopharma Pvt Ltd
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Stelis Biopharma Pvt Ltds pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Stelis Biopharma Pvt Ltd Snapshot 5
Stelis Biopharma Pvt Ltd Overview 5
Key Facts 5
Stelis Biopharma Pvt Ltd - Research and Development Overview 6
Key Therapeutic Areas 6
Stelis Biopharma Pvt Ltd - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Stelis Biopharma Pvt Ltd - Pipeline Products Glance 12
Stelis Biopharma Pvt Ltd - Clinical Stage Pipeline Products 12
Phase I Products/Combination Treatment Modalities 12
Stelis Biopharma Pvt Ltd - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Stelis Biopharma Pvt Ltd - Drug Profiles 14
SBL-005 - Drug Profile 14
Product Description 14
Mechanism Of Action 14
R&D Progress 14
SBL-011 - Drug Profile 15
Product Description 15
Mechanism Of Action 15
R&D Progress 15
SBL-012 - Drug Profile 16
Product Description 16
Mechanism Of Action 16
R&D Progress 16
teriparatide biosimilar - Drug Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
Stelis Biopharma Pvt Ltd - Pipeline Analysis 18
Stelis Biopharma Pvt Ltd - Pipeline Products by Target 18
Stelis Biopharma Pvt Ltd - Pipeline Products by Route of Administration 19
Stelis Biopharma Pvt Ltd - Pipeline Products by Molecule Type 20
Stelis Biopharma Pvt Ltd - Pipeline Products by Mechanism of Action 21
Stelis Biopharma Pvt Ltd - Dormant Projects 22
Stelis Biopharma Pvt Ltd - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
Coverage 24
Secondary Research 24
Primary Research 24
Expert Panel Validation 24
Contact Us 24
Disclaimer 25

List of Tables
Stelis Biopharma Pvt Ltd, Key Facts 5
Stelis Biopharma Pvt Ltd - Pipeline by Indication, 2016 7
Stelis Biopharma Pvt Ltd - Pipeline by Stage of Development, 2016 8
Stelis Biopharma Pvt Ltd - Monotherapy Products in Pipeline, 2016 9
Stelis Biopharma Pvt Ltd - Partnered Products in Pipeline, 2016 10
Stelis Biopharma Pvt Ltd - Partnered Products/ Combination Treatment Modalities, 2016 11
Stelis Biopharma Pvt Ltd - Phase I, 2016 12
Stelis Biopharma Pvt Ltd - Preclinical, 2016 13
Stelis Biopharma Pvt Ltd - Pipeline by Target, 2016 18
Stelis Biopharma Pvt Ltd - Pipeline by Route of Administration, 2016 19
Stelis Biopharma Pvt Ltd - Pipeline by Molecule Type, 2016 20
Stelis Biopharma Pvt Ltd - Pipeline Products by Mechanism of Action, 2016 21
Stelis Biopharma Pvt Ltd - Dormant Developmental Projects,2016 22
Stelis Biopharma Pvt Ltd, Subsidiaries 23

List of Figures
Stelis Biopharma Pvt Ltd - Pipeline by Indication, 2016 7
Stelis Biopharma Pvt Ltd - Pipeline by Stage of Development, 2016 8
Stelis Biopharma Pvt Ltd - Monotherapy Products in Pipeline, 2016 9
Stelis Biopharma Pvt Ltd - Pipeline by Molecule Type, 2016 20

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *